Evaluation of 340B prescription assistance program on healthcare use in chronic obstructive pulmonary disease

20236 citationsJournal Articlegold Open Access

Authors

Leah M. Taliaferro · Ascension Via Christi

Melissa C. Norton · Ascension Via Christi

Samuel Ofei‐Dodoo · University of Kansas

Abstract

This study suggested that access to reduced-cost medications through the federal 340B Drug Pricing Program was associated with a significant reduction in hospitalizations and emergency department visits for patients with COPD, decreasing patients' utilization of healthcare resources.

Topics & Keywords

Pharmaceutical Practices and Patient Outcomes Medication Adherence and Compliance Health Systems, Economic Evaluations, Quality of Life

Publication Details

Published in: Exploratory Research in Clinical and Social Pharmacy

Volume 11, pp. 100295-100295

DOI: 10.1016/j.rcsop.2023.100295

Field-Weighted Citation Impact: 1.08

Command Palette

Evaluation of 340B prescription assistance program on healthcare use in chronic obstructive pulmonary disease

Authors

Abstract

Topics & Keywords

Publication Details